|IACP Member Alert: IACP Successful in Introducing Senate Bill 2825|
IACP Successful in Introducing Senate Bill 2825 - Ensuring Safe Access to Prescription Medication Act of 2014
S. 2825 ‘‘Ensuring Safe Access to Prescription Medication Act of 2014’’ is designed to "amend the Controlled Substances Act to treat as dispensing the delivery of a controlled substance by a pharmacy to a practitioner, pursuant to a patient-specific prescription of the practitioner, under certain circumstances."
"This has been a long-term goal of the Academy," said IACP President Pat Stephens, PharmD. "When we established our 2014 legislative agenda in February, resolving the constructive transfer issue once and for all was one of the top three directives we gave our Washington offices. Even while we keep our focus on monitoring the implementation of the Drug Quality & Security Act, IACP continues its work on other critical issues affecting our members."
Please contact your Senators and ask them to sign onto S. 2825. In doing so, they will be ensuring that patients have continued and safe access to the medications they need.
IACP is working with the House to generate a companion bill for S. 2825 and that is expected to be filed in the next few days.
Please email IACP at firstname.lastname@example.org with any questions or input and don't forget to check out this Friday's Capitol Connections newsletter for additional details on our constructive transfer activities.
Tell us how compounded pharmaceuticals have helped you, someone you know, or how you have helped someone as a practicing compounding pharmacist. Help us protect your continued access to pharmacy compounding!
Share the P3 community and the value and necessity of personalized prescriptions with your friends.